 | • レポートコード：MRC2-11QY04491 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は呼吸器疾患用吸入器のグローバル市場について調査・分析したレポートです。種類別（ドライパウダー吸入器、定量吸入器、その他）市場規模、用途別（喘息、COPD、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別呼吸器疾患用吸入器の競争状況、市場シェア ・世界の呼吸器疾患用吸入器市場：種類別市場規模 2015年-2020年（ドライパウダー吸入器、定量吸入器、その他） ・世界の呼吸器疾患用吸入器市場：種類別市場規模予測 2021年-2026年（ドライパウダー吸入器、定量吸入器、その他） ・世界の呼吸器疾患用吸入器市場：用途別市場規模 2015年-2020年（喘息、COPD、その他） ・世界の呼吸器疾患用吸入器市場：用途別市場規模予測 2021年-2026年（喘息、COPD、その他） ・北米の呼吸器疾患用吸入器市場分析：米国、カナダ ・ヨーロッパの呼吸器疾患用吸入器市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの呼吸器疾患用吸入器市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の呼吸器疾患用吸入器市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの呼吸器疾患用吸入器市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Adherium limited、AstraZeneca、Boehringer Ingelheim GmbH、Chiesi Farmaceutici S.p.A.、GSK plc.、Propeller Health、Teva Pharmaceutical Industries Ltd. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Respiratory disorders have always been a huge challenge for the drug manufacturers and the medical practitioners. In the last couple of decades, this respiratory disorder prevalence has increased tremendously due to some of the reasons such as air pollution, smoking, industrialization among others. To counter these respiratory disorders, scientists have developed various drugs and devices. Extensive efforts have been made to control the disorders such as Asthma and Chronic obstructive pulmonary disorder which affects the majority of the patients.
Globally North America is the largest market for Respiratory Inhalers accounting 35.1% of the total market. This large share is majorly due to, tobacco smoke which is a key factor in the development and progression of COPD. COPD was considered the third leading cause of death in U.S. in 2017, with almost 6% of Americans diagnosed with the disease.
Market Analysis and Insights: Global Respiratory Inhalers Market
The global Respiratory Inhalers market size is projected to reach US$ 29220 million by 2026, from US$ 28800 million in 2020, at a CAGR of 1.3%% during 2021-2026.
Global Respiratory Inhalers Scope and Market Size
Respiratory Inhalers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Respiratory Inhalers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Adherium limited
AstraZeneca
Boehringer Ingelheim GmbH
Chiesi Farmaceutici S.p.A.
GSK plc.
Propeller Health
Teva Pharmaceutical Industries Ltd.
…
Market segment by Type, the product can be split into
Dry Powder Inhaler
Metered Dose Inhaler
Others
Market segment by Application, split into
Asthma
COPD
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Respiratory Inhalers Revenue
1.4 Market by Type
1.4.1 Global Respiratory Inhalers Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Dry Powder Inhaler
1.4.3 Metered Dose Inhaler
1.4.4 Others
1.5 Market by Application
1.5.1 Global Respiratory Inhalers Market Share by Application: 2020 VS 2026
1.5.2 Asthma
1.5.3 COPD
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Inhalers Market Perspective (2015-2026)
2.2 Global Respiratory Inhalers Growth Trends by Regions
2.2.1 Respiratory Inhalers Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Respiratory Inhalers Historic Market Share by Regions (2015-2020)
2.2.3 Respiratory Inhalers Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Respiratory Inhalers Market Growth Strategy
2.3.6 Primary Interviews with Key Respiratory Inhalers Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Respiratory Inhalers Players by Market Size
3.1.1 Global Top Respiratory Inhalers Players by Revenue (2015-2020)
3.1.2 Global Respiratory Inhalers Revenue Market Share by Players (2015-2020)
3.1.3 Global Respiratory Inhalers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Respiratory Inhalers Market Concentration Ratio
3.2.1 Global Respiratory Inhalers Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Respiratory Inhalers Revenue in 2019
3.3 Respiratory Inhalers Key Players Head office and Area Served
3.4 Key Players Respiratory Inhalers Product Solution and Service
3.5 Date of Enter into Respiratory Inhalers Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Respiratory Inhalers Historic Market Size by Type (2015-2020)
4.2 Global Respiratory Inhalers Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Respiratory Inhalers Market Size by Application (2015-2020)
5.2 Global Respiratory Inhalers Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Respiratory Inhalers Market Size (2015-2020)
6.2 Respiratory Inhalers Key Players in North America (2019-2020)
6.3 North America Respiratory Inhalers Market Size by Type (2015-2020)
6.4 North America Respiratory Inhalers Market Size by Application (2015-2020)
7 Europe
7.1 Europe Respiratory Inhalers Market Size (2015-2020)
7.2 Respiratory Inhalers Key Players in Europe (2019-2020)
7.3 Europe Respiratory Inhalers Market Size by Type (2015-2020)
7.4 Europe Respiratory Inhalers Market Size by Application (2015-2020)
8 China
8.1 China Respiratory Inhalers Market Size (2015-2020)
8.2 Respiratory Inhalers Key Players in China (2019-2020)
8.3 China Respiratory Inhalers Market Size by Type (2015-2020)
8.4 China Respiratory Inhalers Market Size by Application (2015-2020)
9 Japan
9.1 Japan Respiratory Inhalers Market Size (2015-2020)
9.2 Respiratory Inhalers Key Players in Japan (2019-2020)
9.3 Japan Respiratory Inhalers Market Size by Type (2015-2020)
9.4 Japan Respiratory Inhalers Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Respiratory Inhalers Market Size (2015-2020)
10.2 Respiratory Inhalers Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Respiratory Inhalers Market Size by Type (2015-2020)
10.4 Southeast Asia Respiratory Inhalers Market Size by Application (2015-2020)
11 India
11.1 India Respiratory Inhalers Market Size (2015-2020)
11.2 Respiratory Inhalers Key Players in India (2019-2020)
11.3 India Respiratory Inhalers Market Size by Type (2015-2020)
11.4 India Respiratory Inhalers Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Respiratory Inhalers Market Size (2015-2020)
12.2 Respiratory Inhalers Key Players in Central & South America (2019-2020)
12.3 Central & South America Respiratory Inhalers Market Size by Type (2015-2020)
12.4 Central & South America Respiratory Inhalers Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Adherium limited
13.1.1 Adherium limited Company Details
13.1.2 Adherium limited Business Overview
13.1.3 Adherium limited Respiratory Inhalers Introduction
13.1.4 Adherium limited Revenue in Respiratory Inhalers Business (2015-2020))
13.1.5 Adherium limited Recent Development
13.2 AstraZeneca
13.2.1 AstraZeneca Company Details
13.2.2 AstraZeneca Business Overview
13.2.3 AstraZeneca Respiratory Inhalers Introduction
13.2.4 AstraZeneca Revenue in Respiratory Inhalers Business (2015-2020)
13.2.5 AstraZeneca Recent Development
13.3 Boehringer Ingelheim GmbH
13.3.1 Boehringer Ingelheim GmbH Company Details
13.3.2 Boehringer Ingelheim GmbH Business Overview
13.3.3 Boehringer Ingelheim GmbH Respiratory Inhalers Introduction
13.3.4 Boehringer Ingelheim GmbH Revenue in Respiratory Inhalers Business (2015-2020)
13.3.5 Boehringer Ingelheim GmbH Recent Development
13.4 Chiesi Farmaceutici S.p.A.
13.4.1 Chiesi Farmaceutici S.p.A. Company Details
13.4.2 Chiesi Farmaceutici S.p.A. Business Overview
13.4.3 Chiesi Farmaceutici S.p.A. Respiratory Inhalers Introduction
13.4.4 Chiesi Farmaceutici S.p.A. Revenue in Respiratory Inhalers Business (2015-2020)
13.4.5 Chiesi Farmaceutici S.p.A. Recent Development
13.5 GSK plc.
13.5.1 GSK plc. Company Details
13.5.2 GSK plc. Business Overview
13.5.3 GSK plc. Respiratory Inhalers Introduction
13.5.4 GSK plc. Revenue in Respiratory Inhalers Business (2015-2020)
13.5.5 GSK plc. Recent Development
13.6 Propeller Health
13.6.1 Propeller Health Company Details
13.6.2 Propeller Health Business Overview
13.6.3 Propeller Health Respiratory Inhalers Introduction
13.6.4 Propeller Health Revenue in Respiratory Inhalers Business (2015-2020)
13.6.5 Propeller Health Recent Development
13.7 Teva Pharmaceutical Industries Ltd.
13.7.1 Teva Pharmaceutical Industries Ltd. Company Details
13.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
13.7.3 Teva Pharmaceutical Industries Ltd. Respiratory Inhalers Introduction
13.7.4 Teva Pharmaceutical Industries Ltd. Revenue in Respiratory Inhalers Business (2015-2020)
13.7.5 Teva Pharmaceutical Industries Ltd. Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Respiratory Inhalers Key Market Segments
Table 2. Key Players Covered: Ranking by Respiratory Inhalers Revenue
Table 3. Ranking of Global Top Respiratory Inhalers Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Respiratory Inhalers Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Dry Powder Inhaler
Table 6. Key Players of Metered Dose Inhaler
Table 7. Key Players of Others
Table 8. Global Respiratory Inhalers Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Respiratory Inhalers Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Respiratory Inhalers Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Respiratory Inhalers Market Share by Regions (2015-2020)
Table 12. Global Respiratory Inhalers Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Respiratory Inhalers Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Respiratory Inhalers Market Growth Strategy
Table 18. Main Points Interviewed from Key Respiratory Inhalers Players
Table 19. Global Respiratory Inhalers Revenue by Players (2015-2020) (Million US$)
Table 20. Global Respiratory Inhalers Market Share by Players (2015-2020)
Table 21. Global Top Respiratory Inhalers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Inhalers as of 2019)
Table 22. Global Respiratory Inhalers by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Respiratory Inhalers Product Solution and Service
Table 25. Date of Enter into Respiratory Inhalers Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Respiratory Inhalers Market Size by Type (2015-2020) (Million US$)
Table 28. Global Respiratory Inhalers Market Size Share by Type (2015-2020)
Table 29. Global Respiratory Inhalers Revenue Market Share by Type (2021-2026)
Table 30. Global Respiratory Inhalers Market Size Share by Application (2015-2020)
Table 31. Global Respiratory Inhalers Market Size by Application (2015-2020) (Million US$)
Table 32. Global Respiratory Inhalers Market Size Share by Application (2021-2026)
Table 33. North America Key Players Respiratory Inhalers Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Respiratory Inhalers Market Share (2019-2020)
Table 35. North America Respiratory Inhalers Market Size by Type (2015-2020) (Million US$)
Table 36. North America Respiratory Inhalers Market Share by Type (2015-2020)
Table 37. North America Respiratory Inhalers Market Size by Application (2015-2020) (Million US$)
Table 38. North America Respiratory Inhalers Market Share by Application (2015-2020)
Table 39. Europe Key Players Respiratory Inhalers Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Respiratory Inhalers Market Share (2019-2020)
Table 41. Europe Respiratory Inhalers Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Respiratory Inhalers Market Share by Type (2015-2020)
Table 43. Europe Respiratory Inhalers Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Respiratory Inhalers Market Share by Application (2015-2020)
Table 45. China Key Players Respiratory Inhalers Revenue (2019-2020) (Million US$)
Table 46. China Key Players Respiratory Inhalers Market Share (2019-2020)
Table 47. China Respiratory Inhalers Market Size by Type (2015-2020) (Million US$)
Table 48. China Respiratory Inhalers Market Share by Type (2015-2020)
Table 49. China Respiratory Inhalers Market Size by Application (2015-2020) (Million US$)
Table 50. China Respiratory Inhalers Market Share by Application (2015-2020)
Table 51. Japan Key Players Respiratory Inhalers Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Respiratory Inhalers Market Share (2019-2020)
Table 53. Japan Respiratory Inhalers Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Respiratory Inhalers Market Share by Type (2015-2020)
Table 55. Japan Respiratory Inhalers Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Respiratory Inhalers Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Respiratory Inhalers Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Respiratory Inhalers Market Share (2019-2020)
Table 59. Southeast Asia Respiratory Inhalers Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Respiratory Inhalers Market Share by Type (2015-2020)
Table 61. Southeast Asia Respiratory Inhalers Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Respiratory Inhalers Market Share by Application (2015-2020)
Table 63. India Key Players Respiratory Inhalers Revenue (2019-2020) (Million US$)
Table 64. India Key Players Respiratory Inhalers Market Share (2019-2020)
Table 65. India Respiratory Inhalers Market Size by Type (2015-2020) (Million US$)
Table 66. India Respiratory Inhalers Market Share by Type (2015-2020)
Table 67. India Respiratory Inhalers Market Size by Application (2015-2020) (Million US$)
Table 68. India Respiratory Inhalers Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Respiratory Inhalers Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Respiratory Inhalers Market Share (2019-2020)
Table 71. Central & South America Respiratory Inhalers Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Respiratory Inhalers Market Share by Type (2015-2020)
Table 73. Central & South America Respiratory Inhalers Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Respiratory Inhalers Market Share by Application (2015-2020)
Table 75. Adherium limited Company Details
Table 76. Adherium limited Business Overview
Table 77. Adherium limited Product
Table 78. Adherium limited Revenue in Respiratory Inhalers Business (2015-2020) (Million US$)
Table 79. Adherium limited Recent Development
Table 80. AstraZeneca Company Details
Table 81. AstraZeneca Business Overview
Table 82. AstraZeneca Product
Table 83. AstraZeneca Revenue in Respiratory Inhalers Business (2015-2020) (Million US$)
Table 84. AstraZeneca Recent Development
Table 85. Boehringer Ingelheim GmbH Company Details
Table 86. Boehringer Ingelheim GmbH Business Overview
Table 87. Boehringer Ingelheim GmbH Product
Table 88. Boehringer Ingelheim GmbH Revenue in Respiratory Inhalers Business (2015-2020) (Million US$)
Table 89. Boehringer Ingelheim GmbH Recent Development
Table 90. Chiesi Farmaceutici S.p.A. Company Details
Table 91. Chiesi Farmaceutici S.p.A. Business Overview
Table 92. Chiesi Farmaceutici S.p.A. Product
Table 93. Chiesi Farmaceutici S.p.A. Revenue in Respiratory Inhalers Business (2015-2020) (Million US$)
Table 94. Chiesi Farmaceutici S.p.A. Recent Development
Table 95. GSK plc. Company Details
Table 96. GSK plc. Business Overview
Table 97. GSK plc. Product
Table 98. GSK plc. Revenue in Respiratory Inhalers Business (2015-2020) (Million US$)
Table 99. GSK plc. Recent Development
Table 100. Propeller Health Company Details
Table 101. Propeller Health Business Overview
Table 102. Propeller Health Product
Table 103. Propeller Health Revenue in Respiratory Inhalers Business (2015-2020) (Million US$)
Table 104. Propeller Health Recent Development
Table 105. Teva Pharmaceutical Industries Ltd. Company Details
Table 106. Teva Pharmaceutical Industries Ltd. Business Overview
Table 107. Teva Pharmaceutical Industries Ltd. Product
Table 108. Teva Pharmaceutical Industries Ltd. Revenue in Respiratory Inhalers Business (2015-2020) (Million US$)
Table 109. Teva Pharmaceutical Industries Ltd. Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Respiratory Inhalers Market Share by Type: 2020 VS 2026
Figure 2. Dry Powder Inhaler Features
Figure 3. Metered Dose Inhaler Features
Figure 4. Others Features
Figure 5. Global Respiratory Inhalers Market Share by Application: 2020 VS 2026
Figure 6. Asthma Case Studies
Figure 7. COPD Case Studies
Figure 8. Other Case Studies
Figure 9. Respiratory Inhalers Report Years Considered
Figure 10. Global Respiratory Inhalers Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Respiratory Inhalers Market Share by Regions: 2020 VS 2026
Figure 12. Global Respiratory Inhalers Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Respiratory Inhalers Market Share by Players in 2019
Figure 15. Global Top Respiratory Inhalers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Inhalers as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Respiratory Inhalers Revenue in 2019
Figure 17. North America Respiratory Inhalers Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Respiratory Inhalers Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Respiratory Inhalers Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Respiratory Inhalers Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Respiratory Inhalers Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Respiratory Inhalers Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Respiratory Inhalers Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
下気道感染症治療の世界市場（～2026年） The infection below the level of larynx is said to be lower respiratory tract infection. Many a times, lower respiratory tract infection is called pneumonia. These infection are not defined uniformly, but epidemiologically, these infections includes flu, bronchitis, bronchiolitis, and pneumonia. The…- 肺/呼吸器ドラッグデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Pulmonary/ Respiratory Drug Delivery Market The global Pulmonary/ Respiratory Drug Delivery market size is projected to reach US$ 32810 million by 2026, from US$ 31560 million in 2020, at a CAGR of 3.7%% during 2021-2026. Global Pulmonary/ Respiratory Drug Delive…
- 呼吸ゲーティングシステムの世界市場（～2026年） Respiratory gating system is essential to the imaging diagnoses and the radiation therapy. The respiratory gating system is expected to grow over the forecast period owing to the increasing adoption of the products across the world. Market Analysis and Insights: Global Respiratory Gating System Mark…
- 気道感染症治療の世界市場（～2026年） Market Analysis and Insights: Global Respiratory Tract Infection Treatment Market The global Respiratory Tract Infection Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Respiratory Tract Infection Treatment S…
- 牛呼吸器疾患治療の世界市場（～2026年） Bovine respiratory disease (BRD) is a multifactorial and complex disorder caused due to combination of more than one microbial pathogens, impaired host immunity, inadequate housing conditions, and environmental factors. The major factor leading to bovine respiratory diseases are host factors, enviro…